Tenofovir Vaginal Gel In 'VOICE' HIV Prevention Study Discontinued: Product Safe But No More Effective Than Placebo

A large-scale clinical trial evaluating whether daily use of an antiretroviral-containing oral tablet or vaginal gel can prevent HIV infection in women is being modified because an interim review found that the gel, an investigational microbicide, was not effective among study participants. On Nov…

Tenofovir Vaginal Gel In 'VOICE' HIV Prevention Study Discontinued: Product Safe But No More Effective Than Placebo

A large-scale clinical trial evaluating whether daily use of an antiretroviral-containing oral tablet or vaginal gel can prevent HIV infection in women is being modified because an interim review found that the gel, an investigational microbicide, was not effective among study participants. On Nov…

Tenofovir Vaginal Gel In 'VOICE' HIV Prevention Study Discontinued: Product Safe But No More Effective Than Placebo

A large-scale clinical trial evaluating whether daily use of an antiretroviral-containing oral tablet or vaginal gel can prevent HIV infection in women is being modified because an interim review found that the gel, an investigational microbicide, was not effective among study participants. On Nov…

Oral Tenofovir Arm To Be Dropped From Major HIV Prevention Trial In Women

VOICE, an HIV prevention trial evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women – daily use of one of two different ARV tablets or of a vaginal gel – will be dropping one of the oral tablets from the study…

A Step Closer To HIV Prevention During Pregnancy, Breastfeeding

Determining whether a promising HIV prevention gel is safe for women to use while they are pregnant or breastfeeding is the aim of a new clinical trial being conducted by the U.S. National Institutes of Health-funded Microbicide Trials Network (MTN)…

Next Page »